Five American CBD makers have been warned by the U.S. Food and Drug Administration for making illegal medical claims in the agency’s most recent crackdown. FDA informed the companies that their claims violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA sent the warnings to Bee Delightful of Austin, Texas; G&L Wellness of Wisconsin Rapids, Wisconsin; New Leaf Pharmaceuticals of Newton, Connecticut; NextL3vel Services Group of Las Vegas, Nevada; and Wellness Biosciences Rx of Houston, Texas. FDA continues to work on clear rules for CBD but occasionally reprimands companies who violate the FD&C Act.
Posted By: HempToday® December 24, 2020
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.